article
Daaboul N, Agulnik JS, Bahig H, Blais N, Boucher MÈ and Bouchard N, Denault MH, Desmeules P, Fiset PO, Florescu M, Jao K, Labbé C, Lecavalier-Barsoum M, Pepe C, Shieh B, Stock-Martineau S, Marcoux N
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives
Curr Oncol
33 (8), 2026.
article
Pouliot F, Lodde M, Besançon M, Castonguay V, Morin-Coulombe A, Fradet V, Fradet Y, Lacombe L, Lévesque É and Marcoux N, Toren P, April G, Arsenault F, Beaulieu A, Singbo N, Veilleux C, Tremblay-Boily M, Tremblay V, Buteau FA, Beauregard JM
Trajectory timelines and treatment efficacy of 177Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases t…
Can Urol Assoc J
20 (6), 2026.
